top of page

What Medical Device Companies Buy: 10 Years of QMS Document Orders

Oct 21
5 min read

Updated: Nov 10

Reviewed by Aaron Lyon, President of A.P. Lyon and former Director of Quality Assurance and International Regulatory, with more than 30 years in medical device quality. Last reviewed November 10, 2026.


Short answer: Across 2,220 orders from 1,407 buyers in 58 countries (December 2015 to September 2026), medical device companies mostly bought one document at a time to close a specific gap. 84% of orders contained only individual procedures, and 87% of those orders were for a single procedure. The procedures bought by the most companies were Unique Device Identification, Software Validation, Post-Market Surveillance, Clinical Evaluation and PSUR. Demand for post-market and clinical documents rose sharply in the years around the EU MDR and fell after it.


Bar chart of the 10 procedures bought by the most medical device companies, led by Unique Device Identification with 154 buyers

About this data


This analysis uses A.P. Lyon's own store records: every completed order from December 2015 through September 2026. A buyer is a unique email address, so one company can appear more than once if several people ordered. Test orders, cancelled orders and refunded orders are excluded. Only aggregate counts are published; no customer, company or order details are shown.


The data reflects A.P. Lyon's catalog and the companies that found it, not the whole medical device industry. It shows what quality and regulatory teams were willing to pay for, which is a useful signal of where documentation gaps appear in practice.


The 15 procedures bought by the most companies


Ranked by the number of different buyers, with the share of all 1,407 buyers in brackets:


  1. Unique Device Identification: 154 buyers (10.9%)

  2. Software Validation: 113 buyers (8.0%)

  3. Post-Market Surveillance: 104 buyers (7.4%)

  4. Clinical Evaluation: 97 buyers (6.9%)

  5. Periodic Safety Update Report (PSUR): 78 buyers (5.5%)

  6. Injection Mold Validation: 72 buyers (5.1%)

  7. Complaint Trending: 69 buyers (4.9%)

  8. Statistical Techniques: 65 buyers (4.6%)

  9. Human Factors and Usability Engineering: 59 buyers (4.2%)

  10. Supplier Management: 58 buyers (4.1%)

  11. Medical Device Quality Agreement for Europe: 57 buyers (4.1%)

  12. Vigilance: 49 buyers (3.5%)

  13. Medical Device Report (MDR): 46 buyers (3.3%)

  14. Clinical Investigation: 46 buyers (3.3%)

  15. Design Transfer: 41 buyers (2.9%)


Two patterns stand out. First, the list is dominated by documents tied to a specific external requirement (UDI, post-market surveillance, PSUR, vigilance, MDR reporting) rather than core QMS procedures such as document control. Second, validation work (software, injection molds, statistical techniques) is a consistent need, regardless of regulatory cycles.


What companies buy first


For most buyers, the first purchase was a single procedure, not a complete system. The most common first purchases were:


  1. Unique Device Identification Procedure (116 buyers)

  2. Software Validation Procedure (88)

  3. Clinical Evaluation Procedure (79)

  4. Post-Market Surveillance Procedure (74)

  5. Injection Mold Validation Procedure (64)


A complete quality management system was the first purchase for 47 buyers, usually companies setting up a QMS from scratch.


Most orders fill one gap


Of 2,220 orders, 1,863 (84%) contained only individual procedures, 280 (13%) included a procedure bundle and 77 (3%) included a complete system. Among the procedure-only orders, 87% were for exactly one procedure.


In practice, this matches how documentation gaps are found: an audit finding, a new regulation, a new product type or a new process exposes one missing procedure, and the team fixes that gap rather than replacing the whole system.


Procedures that are bought together


When companies did buy several procedures in one order, the pairs followed connected workflows:


  • PSUR + Post-Market Surveillance (16 orders)

  • Post-Market Surveillance + Vigilance (10)

  • Purchase Order + Supplier Management (10)

  • Calibration System + Preventive Maintenance (9)

  • Clinical Evaluation + Post-Market Surveillance (9)

  • Quality Agreement for Europe + Quality Agreement for US (8)

  • Label Review and Approval + Unique Device Identification (7)


If you are updating one of these procedures, check its partner: the two documents usually reference each other, and a change in one often requires a change in the other.


Regulation drives document demand


Bar chart of clinical, post-market and UDI document purchases per year from 2017 to 2025, peaking around the EU MDR date of application in 2021

Purchases of clinical evaluation, post-market surveillance, PSUR, vigilance and PMCF documents rose from 28 in 2017 to 113 in 2019 and 125 in 2021, the year the EU Medical Device Regulation began to apply (May 26, 2021). By 2023 they had fallen to 30. UDI documents followed a similar curve, peaking at 59 purchases in 2021.


The lesson for quality teams: documentation demand clusters around regulatory deadlines. The FDA Quality Management System Regulation (QMSR) took effect February 2, 2026, and ISO 9001:2026 was published September 16, 2026. Companies that update early avoid the rush and the audit findings that come with it. See the QMSR and ISO 9001:2026 update packages.


Many buyers come back


285 buyers (20%) placed a second order, and those repeat buyers accounted for about half of all revenue. The median time between a buyer's first and second order was 26 days, which suggests that once one gap is fixed, the neighboring gaps become visible quickly.


What this means if you are building or updating a QMS


  • Start with the requirement that has a deadline or an open audit finding. That is what most companies do, and it keeps the work focused.

  • When you update a procedure, review the procedures it connects to, especially post-market surveillance, PSUR and vigilance, or supplier management and purchasing.

  • Plan regulatory transitions early. The EU MDR curve shows how demand, and pressure on quality teams, peaks right around the deadline.


To build a set from individual procedures with volume discounts applied, use Build Your QMS.


Not sure where your quality system stands? Take the free QMS gap check: about 20 questions, an instant report of your gaps by clause, and the procedures that close each one.


Just getting started? The free Startup Quality Plan shows which procedures you need now, which can wait, and how long they take to put in place.


Frequently asked questions


Which medical device procedure do companies buy most often?


In A.P. Lyon's order history, the Unique Device Identification (UDI) Procedure was bought by the most companies: 154 of 1,407 buyers, or about 11%. It was also the most common first purchase.


Do companies buy a complete QMS or individual procedures?


Mostly individual procedures. 84% of orders contained only individual procedures, and 87% of those were for a single procedure. Complete systems appeared in 3% of orders, typically from companies setting up a QMS for the first time.


Does regulation change which documents companies need?


Yes. Purchases of clinical and post-market documents more than quadrupled between 2017 and 2021, around the EU MDR date of application, then fell by about three quarters by 2023.


How was this data collected?


From A.P. Lyon's own completed store orders, December 2015 to September 2026, excluding test, cancelled and refunded orders. Only aggregate counts are reported. See our editorial standards for how we source and correct content.

Comments


bottom of page